Angewandte
Chemie
DOI: 10.1002/anie.201310136
Asymmetric Catalysis
Desymmetrization of Diolefinic Diols by Enantioselective Amino-
thiocarbamate-Catalyzed Bromoetherification: Synthesis of Chiral
Spirocycles**
Daniel Weiliang Tay, Gulice Y. C. Leung, and Ying-Yeung Yeung*
Abstract: A facile, efficient, and highly diastereo- and
enantioselective bromoetherification of diolefinic diols has
been developed using an amino-thiocarbamate catalyst. Fur-
ther manipulations of the bromoether products enabled entry
into a new class of spirocycles which are distinctively lacking in
the literature.
tant building blocks for synthetic chemists as they typically
resemble the fundamental cores of many valuable pharma-
ceutical intermediates as well as biologically active natural
products.[6]
The challenge in developing an efficient method for
halocyclization lies in improving the rate of nucleophilic
capture as opposed to the racemization of halonium ions
through olefin-to-olefin transfer.[7] Recently, we reported
asymmetric bromolactonizations and bromoaminocycliza-
tions using amino-thiocarbamate catalysts.[8] Herein we are
pleased to disclose the catalytic enantioselective synthesis of
hetero-spirocycles through a double halocyclization strategy.
The first cyclization involves a desymmetrization/asymmetric
halogenation process which gives rise to two quaternary
stereogenic carbon atoms in the cyclic ether products
(Scheme 1). Subsequently, a diastereoselective halocycliza-
tion can be performed to yield a series of chiral hetero-
Chiral spirocycles are a special class of compounds which
has attracted much attention over the past decades. Because
of the inherent rigidity and well-defined three-dimensional
molecular structure, chiral nonracemic spiromolecules have
been used in various areas, including catalysis, metal com-
plexation, and molecular architecture.[1] The unique structural
features of spirocycles also open a new avenue for exploring
new pharmacological spacing.[2] Recently, multifunctional
chiral hetero-spirocycles, having readily modifiable handles,
have garnered significant interest as they are particularly
useful in modern drug discovery.[3] However, facile and
efficient asymmetric pathways towards enantioenriched spi-
rocycles remain sparse. The tremendous difficulty encoun-
tered in controlling the regio- and stereochemistry of
quaternary carbon centers has caused the synthesis of these
privileged scaffolds to remain a challenge for synthetic
chemists.[1]
Halocyclization of olefinic compounds, an important
synthetic transformation that was discovered more than
a century ago,[4] is a powerful method for the construction
of heterocycles. However, it was not until recently that
significant efforts were devoted to the development of
catalytic enantioselective halolactonization, haloetherifica-
tion, and haloaminocyclization.[5] The resulting heterocyclic
intermediates, having modifiable halogen handles, are impor-
Scheme 1. Synthesis of hetero-spirocycles through the asymmetric
bromination and desymmetrization of 1.
spirosystems. This protocol allows access to a class of novel
chiral spirocycles which are distintively missing in the
literature.[1] To the best of our knowledge, this report also
represents the first case of desymmetrizing bromoetherifica-
tion of a diolefinic diol system.[9]
At the initial stage of this project, we screened our library
of cinchona-alkaloid-derived amino-thiocarbamates to look
for a suitable catalyst with which to carry out the desymmet-
rization with good enantioselectivity and diastereoselectivity.
The compound 1 (R = C6H5; for structure see Table 1) and N-
bromosuccinimide (NBS) were used as the substrate and the
halogen source, respectively. We first screened for a suitable
catalyst core and observed that quinine and quinidine gave
better d.r. and e.r. values as compared to cinchonine and
cinchonidine. We then proceeded to examine various phenyl
handles and the 6-alkoxy substituents of quinoline, and the
[*] D. W. Tay, Prof. Dr. Y.-Y. Yeung
Department of Chemistry, National University of Singapore
3 Science Drive 3, Singapore 117543 (Singapore)
E-mail: chmyyy@nus.edu.sg
academic_staff/yeungyy.htm
Dr. G. Y. C. Leung, Prof. Dr. Y.-Y. Yeung
Agency for Science, Technology and Research (A*STAR)
Institute of Chemical & Engineering Sciences
11 Biopolis Way, Helios, #03-08, Singapore 138667 (Singapore)
[**] We thank the National University of Singapore (grant no. 143-000-
509-112), A*STAR-Public Sector Funding (grant no. 143-000-536-
305), and GSK-EDB (grant no. 143-000-564-592) for financial
support. D.T. would like to thank and acknowledge A*STAR for
sponsoring his PhD scholarship.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2014, 53, 1 – 5
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!